Managers / Q4 2021 · view latest →
Aspex Management (HK) Ltd
CIK 0001768375 · 16TH FLOOR, ST. GEORGE'S BUILDING, 2 ICE HOUSE STREET, CENTRAL, K3, NA · 852-34684160
Summary
Aspex Management (Hk) Ltd reported $3.3B in U.S.-listed holdings across 26 positions for Q4 2021.
Its largest position, XPEV, represents 13.5% of the portfolio.
Compared with Q3 2021, the fund opened 2 new positions and exited 3.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ADR · 78.8% · $2.6B
- Common Stock · 11.1% · $365M
- US DOMESTIC · 4.1% · $133M
- Other · 3.9% · $126M
- GLOBAL · 2.2% · $70M
Quarter-over-Quarter Changes full breakdown →
vs Q3 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| FUTUFUTU HLDGS LTD | NEW | +3.87M | 3.87M | +$168M | $168M |
| FTCHQFARFETCH LTD | NEW | +3.03M | 3.03M | +$101M | $101M |
| BEKEKE HLDGS INC | ADDED | +6.50M | 9.00M | +$135M | $181M |
| LAM RESEARCH CORP | SOLD OUT | −262.9K | 0 | −$150M | $0 |
| APIAGORA INC | SOLD OUT | −783.5K | 0 | −$23M | $0 |
| BZKANZHUN LIMITED | SOLD OUT | −525.0K | 0 | −$19M | $0 |
| HTHTHUAZHU GROUP LTD | TRIMMED | −400.0K | 2.50M | −$40M | $93M |
| NTESNETEASE INC | ADDED | +351.1K | 3.27M | +$84M | $333M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2021
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | XPEVXPENG INChistory → | ADS | 13.52% | $442M | 8.78M |
| 2 | JDJD.COM INChistory → | SPON ADR CL A | 12.26% | $401M | 5.72M |
| 3 | GDSGDS HLDGS LTDhistory → | SPONSORED ADS | 10.92% | $357M | 7.57M |
| 4 | NTESNETEASE INChistory → | SPONSORED ADS | 10.17% | $333M | 3.27M |
| 5 | QFIN360 DIGITECH INChistory → | AMERICAN DEP | 6.37% | $208M | 9.09M |
| 6 | MUMICRON TECHNOLOGY INChistory → | COM | 5.73% | $187M | 2.01M |
| 7 | BEKEKE HLDGS INChistory → | SPONSORED ADS | 5.54% | $181M | 9.00M |
| 8 | FUTUFUTU HLDGS LTDhistory → | SPON ADS CL A | 5.12% | $168M | 3.87M |
| 9 | ZTOZTO EXPRESS CAYMAN INChistory → | SPONSORED ADS A | 5.07% | $166M | 5.87M |
| 10 | LILI AUTO INChistory → | SPONSORED ADS | 4.71% | $154M | 4.80M |
| 11 | HTHTHUAZHU GROUP LTD | SPONSORED ADS · NOTE 3.000% 5/0 | 4.57% | $149M | 52.50M |
| 12 | FTCHQFARFETCH LTDhistory → | ORD SH CL A | 3.09% | $101M | 3.03M |
| 13 | SEA LTD | NOTE 2.375%12/0 | 2.35% | $77M | 30.00M |
| 14 | TSPHTUSIMPLE HLDGS INChistory → | CL A | 2.33% | $76M | 2.12M |
| 15 | IQIYI INC | NOTE 2.000% 4/0 | 1.78% | $58M | 80.70M |
| 16 | NEW FRONTIER HEALTH CORP | ORD SHS | 1.43% | $47M | 4.08M |
| 17 | NIONIO INChistory → | SPON ADS | 1.05% | $34M | 1.08M |
| 18 | DDLDINGDONG CAYMAN LTDhistory → | ADS | 1.00% | $33M | 2.01M |
| 19 | YATSEN HLDG LTD | ADS | 0.86% | $28M | 13.13M |
| 20 | VICARIOUS SURGICAL INC | COM CL A | 0.84% | $28M | 2.60M |
| 21 | ARTISAN ACQUISITION CORP | UNIT 03/26/2026 | 0.39% | $13M | 1.25M |
| 22 | HELLO GROUP INC | NOTE 1.250% 7/0 | 0.37% | $12M | 14.00M |
| 23 | MAGNUM OPUS ACQUISITION LTD | UNIT 06/03/2026 | 0.32% | $10M | 991.4K |
| 24 | EMSMART SH GLOBAL LTD | ADS | 0.20% | $7M | 4.50M |
| 25 | NEW FRONTIER HEALTH CORP W | W EXP 11/30/202 | 0.01% | $472,000 | 162.5K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $6.9B | 30 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $4.9B | 25 | Feb 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $4.7B | 27 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $4.6B | 28 | Aug 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $3.9B | 30 | May 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $3.7B | 32 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $3.8B | 30 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $4.7B | 37 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $3.7B | 35 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $3.4B | 35 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $3.2B | 30 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $3.4B | 30 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $4.1B | 35 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | Under review | 31 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $3.4B | 29 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $4.0B | 30 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $2.5B | 27 | May 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $3.3B | 26 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $3.0B | 27 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $3.1B | 24 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $2.5B | 21 | May 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $2.5B | 23 | Feb 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $1.6B | 18 | Nov 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $815M | 13 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $722M | 16 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $550M | 12 | Feb 5, 2020 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.